| Year |
Citation |
Score |
| 2009 |
Middleton MK, Zukas AM, Rubinstein T, Kinder M, Wilson EH, Zhu P, Blair IA, Hunter CA, Puré E. 12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis. Infection and Immunity. 77: 5690-700. PMID 19822654 DOI: 10.1128/Iai.00560-09 |
0.565 |
|
| 2008 |
Zhao L, Lee E, Zukas AM, Middleton MK, Kinder M, Acharya PS, Hall JA, Rader DJ, Puré E. CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1283-9. PMID 18420998 DOI: 10.1161/Atvbaha.108.165753 |
0.54 |
|
| 2007 |
Zhao L, Hall JA, Levenkova N, Lee E, Middleton MK, Zukas AM, Rader DJ, Rux JJ, Puré E. CD44 regulates vascular gene expression in a proatherogenic environment. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 886-92. PMID 17272751 DOI: 10.1161/01.Atv.0000259362.10882.C5 |
0.561 |
|
| 2006 |
Middleton MK, Zukas AM, Rubinstein T, Jacob M, Zhu P, Zhao L, Blair I, Puré E. Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. The Journal of Experimental Medicine. 203: 2529-40. PMID 17043146 DOI: 10.1084/Jem.20061444 |
0.567 |
|
| 2006 |
Middleton MK, Rubinstein T, Puré E. Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase. Journal of Immunology (Baltimore, Md. : 1950). 176: 265-74. PMID 16365418 DOI: 10.4049/Jimmunol.176.1.265 |
0.625 |
|
| 2005 |
Ali K, Middleton M, Puré E, Rader DJ. Apolipoprotein E suppresses the type I inflammatory response in vivo. Circulation Research. 97: 922-7. PMID 16179587 DOI: 10.1161/01.Res.0000187467.67684.43 |
0.621 |
|
| Show low-probability matches. |